Deadly combination of Vaping-lnduced lung injury and Influenza: case report
E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combi...
Saved in:
Published in | Diagnostic pathology Vol. 15; no. 1; pp. 83 - 7 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
09.07.2020
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS).
A 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission.
This case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome. |
---|---|
AbstractList | E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS). This case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome. Abstract Background E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS). Case presentation A 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission. Conclusion This case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome. E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS). A 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission. This case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome. Background E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS). Case presentation A 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission. Conclusion This case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome. Background E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS). Case presentation A 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission. Conclusion This case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome. Keywords: Vaping, Influenza, Acute respiratory distress syndrome (ARDS), Diffuse alveolar damage (DAD), Case report E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS).BACKGROUNDE-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another consideration is that EVALI may have an adverse influence on the outcome of intercurrent respiratory infections. We document this deadly combination in the case of a young man who had EVALI and simultaneous 41 Influenza-A infection leading to severe Acute Respiratory Distress Syndrome (ARDS).A 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission.CASE PRESENTATIONA 27-year-old male with a history of tobacco and vaping use was admitted to hospital after two weeks of flu-like symptoms, diarrhea and vomiting. A chest x-ray was consistent with multifocal pneumonia, and microbiological tests were positive for Influenza-A and methicillin-sensitive Staphalacoccus aureus (MSSA). Bronchoscopy provided evidence of acute inhalational injury. After admission, he acutely decompensated with severe hypoxia and hypotension; he required intubation, sedation and vasopressors. He developed sepsis with acute kidney failure, liver failure, biventricular systolic dysfunction and severe rhabdomyolysis. He was placed on veno-venous (VV) extracorporeal membrane oxygenation (ECMO) initially and later changed to Veno-Arterial (VA) ECMO. Nevertheless, the patient continued to deteriorate, and he expired two weeks after admission.This case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome.CONCLUSIONThis case documents that EVALI can act as a major factor leading a respiratory infection to progress into severe ARDS with a fatal outcome. |
ArticleNumber | 83 |
Audience | Academic |
Author | Salas de Armas, Ismael A. Akkanti, Bindu H. Patel, Jayeshkumar A. Kar, Biswajit Zhao, Bihong Gregoric, Igor D. Elzamly, Shaimaa Pelicon, Kevin Buja, L. Maximilian Hussain, Rahat Dinh, Kha Akay, Mehmet Petek, Klemen Patel, Manish K. |
Author_xml | – sequence: 1 givenname: Bindu H. surname: Akkanti fullname: Akkanti, Bindu H. – sequence: 2 givenname: Rahat surname: Hussain fullname: Hussain, Rahat – sequence: 3 givenname: Manish K. surname: Patel fullname: Patel, Manish K. – sequence: 4 givenname: Jayeshkumar A. surname: Patel fullname: Patel, Jayeshkumar A. – sequence: 5 givenname: Kha surname: Dinh fullname: Dinh, Kha – sequence: 6 givenname: Bihong surname: Zhao fullname: Zhao, Bihong – sequence: 7 givenname: Shaimaa surname: Elzamly fullname: Elzamly, Shaimaa – sequence: 8 givenname: Kevin surname: Pelicon fullname: Pelicon, Kevin – sequence: 9 givenname: Klemen surname: Petek fullname: Petek, Klemen – sequence: 10 givenname: Ismael A. surname: Salas de Armas fullname: Salas de Armas, Ismael A. – sequence: 11 givenname: Mehmet surname: Akay fullname: Akay, Mehmet – sequence: 12 givenname: Biswajit surname: Kar fullname: Kar, Biswajit – sequence: 13 givenname: Igor D. surname: Gregoric fullname: Gregoric, Igor D. – sequence: 14 givenname: L. Maximilian orcidid: 0000-0001-8386-7029 surname: Buja fullname: Buja, L. Maximilian |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32646452$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kkuPFCEUhYkZ4zz0D7gwlbhxUyPvolyYTMZXx0ncqFsCFJR0aGihykn766W7Z0z3xBhCuIFzPnLhnIOTmKIF4DmClwgJ_rogAiFsIa4T9r1obx-BM9RR3iLW85OD-hScl7KEkDKG4RNwSjCnnDJ8Bj6_s2oIm8aklfZRTT7FJrnmu1r7OLYhDrOxQxPmODY-Lue8aVQcmkV0Ybbxt3rTGFVsk-065ekpeOxUKPbZ3XoBvn14__X6U3vz5ePi-uqmNYyTqVV4gMY4bI11XFgsuIUdEkxAqIwjQncaYaUE50YY1kNCMGbV6ZRGbsCEXIDFnjsktZTr7Fcqb2RSXu42Uh6lypM3wUpBGeHaaIENo4hhQTnujdbYclErXVlv96z1rFd2MDZOWYUj6PFJ9D_kmH7JjlAuGKuAV3eAnH7Otkxy5YuxIaho01wkpphADpGgVfrygXSZ5hzrU21VtMO8pweqUdUGfHSp3mu2UHnFCRJ9_XVRVZf_UNUx2JU3NSfO1_0jw4vDRv92eB-FKhB7gcmplGydNH7aBaKSfZAIym3q5D51sqZO7lInb6sVP7De0_9j-gNFVteZ |
CitedBy_id | crossref_primary_10_26508_lsa_202101246 crossref_primary_10_1007_s12016_025_09026_5 crossref_primary_10_1097_CCM_0000000000005299 crossref_primary_10_1007_s40278_021_96052_2 crossref_primary_10_1016_j_biocel_2021_106039 crossref_primary_10_4103_atm_atm_62_21 crossref_primary_10_1186_s13000_023_01345_5 crossref_primary_10_1096_fj_202201392R crossref_primary_10_1177_17534259231181029 crossref_primary_10_1016_j_pharmthera_2021_108006 crossref_primary_10_1007_s11255_024_04278_0 |
Cites_doi | 10.1172/JCI128531 10.1001/jama.2009.1582 10.1016/0163-4453(90)94077-d 10.1186/1746-1596-8-174 10.1155/2019/1540761 10.1164/rccm.201912-2332WS 10.7759/cureus.6350 10.1155/2020/7151834 10.1056/NEJMoa1916433 10.1148/radiol.2020192585 10.4103/1947-2714.1539269 10.1016/j.carrev.2017.04.017 10.1136/bcr-2018-226610 10.3390/toxics8010008 10.1016/j.rce.2014.11.00930.9 10.1186/s13054-019-2491-9 10.1056/NEJMe1912032 10.1097/PAF.0000000000000533 10.1016/S0140-6736(19)32679-0 10.1002/dc.24343 10.7759/cureus.2786 10.1073/pnas.1920925117 10.1056/NEJMoa1915314 10.1016/j.ensci.2017.03.006 10.1002/ppul.24787 10.1038/s41392-020-0148-4 10.7759/cureus.7571 10.1056/NEJMp1916171 10.1016/j.amjmed.2019.09.015 10.1002/JPER.18-0045a.99 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2020 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FR3 FYUFA GHDGH K9. M0S M1P M7Z P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13000-020-00998-w |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Biochemistry Abstracts 1 Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Biochemistry Abstracts 1 Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1746-1596 |
EndPage | 7 |
ExternalDocumentID | oai_doaj_org_article_84536bcb82c5415284629cbb2e68629b PMC7346855 A631891308 32646452 10_1186_s13000_020_00998_w |
Genre | Journal Article Case Reports |
GroupedDBID | --- 0R~ 29G 2WC 53G 5GY 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M~E O5R O5S OK1 OVT PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW ~8M -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7XB 8FD 8FK AZQEC COVID DWQXO FR3 K9. M7Z P64 PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c563t-a2d0ccf2ecef68e286e07185800acf38b7b12aa866c8c59033225563fab1fd233 |
IEDL.DBID | 7X7 |
ISSN | 1746-1596 |
IngestDate | Wed Aug 27 01:21:03 EDT 2025 Thu Aug 21 17:50:40 EDT 2025 Thu Jul 10 23:53:55 EDT 2025 Fri Jul 25 20:04:29 EDT 2025 Tue Jun 17 21:55:42 EDT 2025 Tue Jun 10 20:12:31 EDT 2025 Thu Jan 02 22:51:11 EST 2025 Tue Jul 01 04:29:38 EDT 2025 Thu Apr 24 23:16:23 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Vaping Case report Diffuse alveolar damage (DAD) Acute respiratory distress syndrome (ARDS) Influenza |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-a2d0ccf2ecef68e286e07185800acf38b7b12aa866c8c59033225563fab1fd233 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Report-3 ObjectType-Case Study-4 ObjectType-Case Study-2 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ORCID | 0000-0001-8386-7029 |
OpenAccessLink | https://www.proquest.com/docview/2424726944?pq-origsite=%requestingapplication% |
PMID | 32646452 |
PQID | 2424726944 |
PQPubID | 54778 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_84536bcb82c5415284629cbb2e68629b pubmedcentral_primary_oai_pubmedcentral_nih_gov_7346855 proquest_miscellaneous_2423060184 proquest_journals_2424726944 gale_infotracmisc_A631891308 gale_infotracacademiconefile_A631891308 pubmed_primary_32646452 crossref_citationtrail_10_1186_s13000_020_00998_w crossref_primary_10_1186_s13000_020_00998_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-07-09 |
PublicationDateYYYYMMDD | 2020-07-09 |
PublicationDate_xml | – month: 07 year: 2020 text: 2020-07-09 day: 09 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Diagnostic pathology |
PublicationTitleAlternate | Diagn Pathol |
PublicationYear | 2020 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | AK Werner (998_CR19) 2020; 382 A Mittal (998_CR12) 2020; 12 T Hamano (998_CR26) 2017; 7 998_CR8 E Geladari (998_CR27) 2018; 19 BJ Carroll (998_CR7) 2020; 55 J Sagan (998_CR30) 2018; 24 C Bai (998_CR13) 2013; 8 AJ Youmans (998_CR9) 2020; 41 998_CR14 S Kligerman (998_CR6) 2020; 294 998_CR31 AM Ibrahim (998_CR28) 2018; 10 E Ayala (998_CR22) 2009; 302 DP Blagev (998_CR3) 2019; 394 FB Boudi (998_CR16) 2019; 11 AS ArRejaie (998_CR21) 2019; 90 JC Ordofiez (998_CR25) 2015; 215 FA Ocampo-Gonzalez (998_CR11) 2020; 48 MC Madison (998_CR15) 2019; 129 BC Blount (998_CR20) 2020; 382 D Wu (998_CR17) 2020; 117 R Qarajeh (998_CR4) 2020; 133 DC Christiani (998_CR5) 2020; 382 MF Fadila (998_CR24) 2015; 7 M Runnstrom (998_CR29) 2018; 11 998_CR2 B Gay (998_CR10) 2020; 2020 L Tan (998_CR32) 2020; 5 W Foulkes (998_CR23) 1990; 21 BA King (998_CR1) 2020; 382 B Duffy (998_CR18) 2020; 8 37147671 - Diagn Pathol. 2023 May 5;18(1):58 |
References_xml | – volume: 129 start-page: 4290 issue: 10 year: 2019 ident: 998_CR15 publication-title: J Clin Invest doi: 10.1172/JCI128531 – volume: 302 start-page: 1863 issue: 17 year: 2009 ident: 998_CR22 publication-title: JAMA. doi: 10.1001/jama.2009.1582 – volume: 21 start-page: 303 issue: 3 year: 1990 ident: 998_CR23 publication-title: J Inf Secur doi: 10.1016/0163-4453(90)94077-d – volume: 8 start-page: 174 year: 2013 ident: 998_CR13 publication-title: Diagn Pathol doi: 10.1186/1746-1596-8-174 – volume: 24 start-page: 118 issue: 4 year: 2018 ident: 998_CR30 publication-title: Klin Mikrobiol 324 Infekc Lek – ident: 998_CR31 doi: 10.1155/2019/1540761 – ident: 998_CR2 doi: 10.1164/rccm.201912-2332WS – volume: 11 start-page: e6350 issue: 12 year: 2019 ident: 998_CR16 publication-title: Cureus doi: 10.7759/cureus.6350 – volume: 2020 start-page: 7151834 year: 2020 ident: 998_CR10 publication-title: Case Rep Pulmonol doi: 10.1155/2020/7151834 – ident: 998_CR8 – volume: 382 start-page: 697 issue: 80 year: 2020 ident: 998_CR20 publication-title: N Eng/ J Med doi: 10.1056/NEJMoa1916433 – volume: 294 start-page: 491 issue: 3 year: 2020 ident: 998_CR6 publication-title: Radiology. doi: 10.1148/radiol.2020192585 – volume: 7 start-page: 122 issue: 3 year: 2015 ident: 998_CR24 publication-title: N Am J Med Sci doi: 10.4103/1947-2714.1539269 – volume: 19 start-page: 37 issue: 1 Pt A year: 2018 ident: 998_CR27 publication-title: Cardiovasc Revasc Med doi: 10.1016/j.carrev.2017.04.017 – volume: 11 start-page: e226610 issue: 1 year: 2018 ident: 998_CR29 publication-title: BMJ Case Rep doi: 10.1136/bcr-2018-226610 – volume: 8 start-page: 8 issue: 1 year: 2020 ident: 998_CR18 publication-title: Toxics doi: 10.3390/toxics8010008 – volume: 215 start-page: 295 issue: 5 year: 2015 ident: 998_CR25 publication-title: Rev Clin Esp doi: 10.1016/j.rce.2014.11.00930.9 – ident: 998_CR14 doi: 10.1186/s13054-019-2491-9 – volume: 382 start-page: 960 issue: 10 year: 2020 ident: 998_CR5 publication-title: N Engl J Med doi: 10.1056/NEJMe1912032 – volume: 41 start-page: 1 issue: 1 year: 2020 ident: 998_CR9 publication-title: Am J Forensic Med Pathol doi: 10.1097/PAF.0000000000000533 – volume: 394 start-page: 2073 issue: 10214 year: 2019 ident: 998_CR3 publication-title: Lancet. doi: 10.1016/S0140-6736(19)32679-0 – volume: 48 start-page: 174 issue: 2 year: 2020 ident: 998_CR11 publication-title: Diagn Cytopathol doi: 10.1002/dc.24343 – volume: 10 start-page: e2786 issue: 6 year: 2018 ident: 998_CR28 publication-title: Cureus doi: 10.7759/cureus.2786 – volume: 117 start-page: 6349 issue: 12 year: 2020 ident: 998_CR17 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1920925117 – volume: 382 start-page: 1589 issue: 17 year: 2020 ident: 998_CR19 publication-title: N Engl J Med doi: 10.1056/NEJMoa1915314 – volume: 7 start-page: 15 year: 2017 ident: 998_CR26 publication-title: eNeurologica/Sci doi: 10.1016/j.ensci.2017.03.006 – volume: 55 start-page: 1712 issue: 7 year: 2020 ident: 998_CR7 publication-title: Pediatr Pulmonol doi: 10.1002/ppul.24787 – volume: 5 start-page: 33 issue: 1 year: 2020 ident: 998_CR32 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-020-0148-4 – volume: 12 start-page: e7571 issue: 4 year: 2020 ident: 998_CR12 publication-title: Cureus doi: 10.7759/cureus.7571 – volume: 382 start-page: 689 issue: 8 year: 2020 ident: 998_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMp1916171 – volume: 133 start-page: e147 issue: 4 year: 2020 ident: 998_CR4 publication-title: Am J Med doi: 10.1016/j.amjmed.2019.09.015 – volume: 90 start-page: 367 issue: 4 year: 2019 ident: 998_CR21 publication-title: J Periodontol doi: 10.1002/JPER.18-0045a.99 – reference: 37147671 - Diagn Pathol. 2023 May 5;18(1):58 |
SSID | ssj0045520 |
Score | 2.2741072 |
Snippet | E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping devices. Another... Background E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use vaping... Abstract Background E-cigarette and vaping use-associated acute lung injury (EVALI) has been recently recognized as a complication in individuals who use... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 83 |
SubjectTerms | Acute Lung Injury - etiology Acute respiratory distress syndrome (ARDS) Adult Adult respiratory distress syndrome Bronchoscopy Case Report Case reports Cigarettes Diarrhea Diffuse alveolar damage (DAD) Electronic cigarettes Electronic Nicotine Delivery Systems Emergency medical care Fatal Outcome Health aspects Humans Hypotension Hypoxia Infections Influenza Influenza A Influenza A virus Influenza, Human - complications Injuries Intensive care Intubation Laboratories Liver diseases Lungs Male Metabolism Methicillin Oxygenation Pneumonia Renal failure Respiratory distress syndrome Respiratory Distress Syndrome - etiology Rhabdomyolysis Sepsis Severe acute respiratory syndrome coronavirus 2 Staphylococcal Infections - complications Tetrahydrocannabinol THC Tobacco Vaping Vaping - adverse effects Vomiting |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_SUy-itOpqWyIIHiR0N1-b7a2fVEVPVnoLSTbBymNfaV8p7V_fmWTf4y2CXrxuJmzym5nMDMnMEPLBYLall8ABXfdM8ihY14qO6aSdAY8gCI35zt--6_ML-eVSXa61-sI3YaU8cAFu30gltA_e8KDQ2IC95F3wnkfMbeg8nr5g85bBVDmDpVK8XqbIGL1_i5c2NcNQCV0iw-4nZihX6__zTF4zStMHk2sW6OwFeT66jvSwLPkleRaHLfL1BJg0e6AgOBDjZpjpPNGfDvOg2GzogXU9nYFK06vhNwBI3dDTz6U1yaM7oAHMGC03B9vk4uz0x_E5GxsksKC0WDDH-zqExGOISZvIjY7gMRgFTqALSRjf-oY7wFwHE1RXC9RemJmcb1LPhXhFNob5EN8Qqjvlpe5l4zh232iw00Hqk-YOeAaRZkWaJV42jNXDsYnFzOYowmhbMLaAsc0Y2_uKfFrNuS61M_5KfYRsWFFi3ev8AaTBjtJg_yUNFfmITLSonbC84MYkA9gk1rmyhxrOsA7-DRvamVCCVoXp8FIM7KjVtxZTaVpM_ZUVeb8axpn4Um2I87tMI7DGjQGa10VqVlsCVzlfJFekncjTZM_TkeHqV6753QqpjVJv_wdI78gmz6rQsrrbIRuLm7u4C67Vwu9lLXoCvtMcPg priority: 102 providerName: Directory of Open Access Journals |
Title | Deadly combination of Vaping-lnduced lung injury and Influenza: case report |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32646452 https://www.proquest.com/docview/2424726944 https://www.proquest.com/docview/2423060184 https://pubmed.ncbi.nlm.nih.gov/PMC7346855 https://doaj.org/article/84536bcb82c5415284629cbb2e68629b |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbtQw0IL2wgWBeKWUlZGQOCCriV9xuKA-KSAqhCjam2U7DrRaJaW7VQVfz4yTDY2QeskhHiuZlz3j8cwQ8spgtqWXwAGd10zyKFhViorpRjsDFkEQGvOdP5_o41P5ca7mw4HbcrhWuV4T00JddwHPyHcwjaHEtEv57uIXw65RGF0dWmjcJZtYugylupyPDpdUiufrRBmjd5YYuskZOkxoGBl2PdmMUs3-_1fmG1vT9NrkjX3o6AG5PxiQdLfn-ENyJ7aPyKcDYNXiNwVUwNNNxKZdQ787zIZii7YGBtZ0AYpNz9pzICN1bU0_9A1K_ri3NMBmRvv4wWNyenT4bf-YDW0SWFBarJjjdR5Cw2OIjTaRGx3BbjAKTEEXGmF86QvugPI6mKCqXKAOw8zG-aKpuRBPyEbbtfEZobpSXupaFo5jD44C-x00daO5A86Bv5mRYk0vG4Ya4tjKYmGTL2G07WlsgcY20dheZ-TNOOeir6BxK_QesmGExOrX6UV3-cMOymSNVEL74A0PCg0QsKF4FbznEfNdKp-R18hEizoKvxfckGoASGK1K7urYSWr4NuA0PYEEnQrTIfXYmAH3V7af5KYkZfjMM7E-2pt7K4SjMBKNwZgnvZSM6IEBnMKJ2eknMjTBOfpSHv2M1X-LoXURqmt23_rObnHk5CXLK-2ycbq8iq-ANNp5WdJP2Zkc-_w5MvXWTqAgOf7efEXdFsYPA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqcoALAvFKKWAkEAdkNXFix0FCqFCqXbbtqUV7M7bjQNEqKd2tVuVH8RuZcR40Quqt1_VYa898nkfsmSHklcJsS5uBBGRcsoz7lBV5WjBZSaPAI3CpxHznwyM5Ocm-zMV8g_zpc2HwWWWvE4OiLhuH38h3MI0hx7TL7MPZL4Zdo_B2tW-h0cJi5i_XELIt30_3QL6vOd__fPxpwrquAswJma6Y4WXsXMW985VUnivpwcwqAZ6TcVWqbG4TbmCh0iknijhFyMPMytikKjl-AAWVfwsMb4zBXj4fArxMCB73iTlK7izxqihmGKChI6bYemT8Qo-A_y3BFVM4fqZ5xe7t3yN3O4eV7rYIu082fP2AzPYAGotLCqyDyDoIlzYV_Wow-4ot6hIAU9IFKBJ6Wv8EsVFTl3TaNkT5bd5RB8aTtvcVD8nJjTDwEdmsm9o_IVQWwmayzBLDsedHgv0VqrKS3ABSIL6NSNLzS7uuZjm2zljoELsoqVsea-CxDjzW64i8HeactRU7rqX-iGIYKLHadvihOf-uu8OrVSZSaZ1V3Al0eMBn44WzlnvMrylsRN6gEDXqBFieM11qA2wSq2vpXQmas4D_hg1tjyjhLLvxcA8D3emSpf6H_Ii8HIZxJr6Pq31zEWhSrKyjgOZxi5phS-Cgh-vriOQjPI32PB6pT3-ESuN5mkklxNb1y3pBbk-ODw_0wfRo9pTc4QHwOYuLbbK5Or_wz8BtW9nn4axQ8u2mD-dfZolRpQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Deadly+combination+of+Vaping-lnduced+lung+injury+and+Influenza%3A+case+report&rft.jtitle=Diagnostic+pathology&rft.au=Akkanti%2C+Bindu+H&rft.au=Hussain%2C+Rahat&rft.au=Patel%2C+Manish+K&rft.au=Patel%2C+Jayeshkumar+A&rft.date=2020-07-09&rft.issn=1746-1596&rft.eissn=1746-1596&rft.volume=15&rft.issue=1&rft.spage=83&rft_id=info:doi/10.1186%2Fs13000-020-00998-w&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1746-1596&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1746-1596&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1746-1596&client=summon |